Category: Alzheimer’s disease

Biogen gives up on aducanumab (Aduhelm)

On January 31, Biogen put out a press release indicating that it “plans to reprioritize its resources in Alzheimer’s disease” by halting development and marketing of the anti-amyloid monoclonal antibody aducanumab (Aduhelm). Patients currently...

My REM sleep behavior disorder

About six weeks ago, I was awakened from sleep by a fall to the floor. I remember my dream vividly.  I was being chased by someone trying to kill me. I stumbled on a path...